Ivermectin EP impurity E
Ref. 3D-II167726
| Unbestimmte Größe | Nachfragen |
Produktinformation
- (5-O,12-didemethyl-12-ethyl-22,23-dihydroavermectin A1a (12-demethyl-12-ethyl-H2B1a)
Ivermectin EP impurity E is an impurity of Ivermectin. It is a natural metabolite of Ivermectin that was first identified in 1979. It is not currently used as a drug, but it has been studied for its potential to treat Parkinson's disease and other neurological disorders. Ivermectin EP impurity E has also been shown to have anti-inflammatory properties, which may be due to its inhibition of prostaglandin synthesis.
Ivermectin EP impurity E is a natural metabolite of Ivermectin which was first identified in 1979. It is not currently used as a drug, but it has been studied for its potential to treat Parkinson's disease and other neurological disorders. Ivermectin EP impurity E has also been shown to have anti-inflammatory properties, which may be due to its inhibition of prostaglandins synthesis.
Chemische Eigenschaften
Technische Anfrage zu: 3D-II167726 Ivermectin EP impurity E
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
